Breaking News

Euro-Area Economy Shows Signs of Weakening as Surveys Miss Forecasts
Tweet TWEET

BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, March 13,

BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and
Host Conference Call on Wednesday, March 13, 2013

WALTHAM, Mass., March 6, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc.
(Nasdaq:BGMD) today announced that the company will host a conference call and
webcast on Wednesday, March 13 at 8:30 a.m. Eastern Time to discuss its fourth
quarter and year-end 2012 financial results. The call and webcast will follow
the release of the fourth quarter financial results before the market opens.

Conference Call Details

To access the live conference call on March 13 at 8:30 a.m. Eastern Time via
phone, please dial (877) 845-1016 from the U.S. and Canada, or (708) 290-1155
internationally. Please dial in approximately ten minutes prior to the start
of the call.

To access the live and subsequently archived webcast of the conference call,
go to the Investor Relations section of the company's website
http://investor.bg-medicine.com/events.cfm. Please connect to the website at
least 15 minutes prior to the call to allow for any software download that may
be necessary.

About BG Medicine

BG Medicine, Inc. (Nasdaq:BGMD) is a diagnostics company focused on the
development and commercialization of novel cardiovascular tests to address
significant unmet medical needs, improve patient outcomes and reduce
healthcare costs. The Company has two products: the BGM Galectin-3® test for
use in patients with chronic heart failure is available in the United States
and Europe; and the CardioSCORE™ test for the risk prediction of major
cardiovascular events will be launched in Europe in the first half of 2013.
For additional information about BG Medicine, heart failure and galectin-3
testing, please visit www.bg-medicine.com and www.galectin-3.com.

The BG Medicine Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10352

CONTACT: Chuck Abdalian
         EVP & Chief Financial Officer
         (781) 434-0210

BG Medicine Inc. logo
 
Press spacebar to pause and continue. Press esc to stop.